Join to View Full Profile
Memorial Sloan Kettering Cancer Center New York1275 York AvenueNew York, NY 10021
Dr. Ghosh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Hematopoietic stem cell transplantation
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2019
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2016- Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 2008 - 2013
Mysore Medical CollegeClass of 2002
Medizinische HochschulePh.D.
Certifications & Licensure
NY State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma.Harper Hubbeling, Doris Leithner, Emily A Silverman, Jessica Flynn, Sean Devlin
Clinical Cancer Research. 2024-11-15 - 25 citationsPhase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors.H Park, G I Shapiro, X Gao, A Mahipal, J Starr
ESMO Open. 2022-10-01 - 12 citationsCalreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.Mathieu Gigoux, Morten O Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe
Science Translational Medicine. 2022-06-15
Press Mentions
- GOPIO Manhattan Chapter Conducts Seminar to Educate Public on Covid-19, VaccinesMarch 14th, 2021
Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017
Grant Support
- Nitric oxide induced soluble guanylate cyclase dysfunction or activation: Implications as a disease indicator or in therapyCLEVELAND CLINIC LERNER COM-CWRU2020–2025
- Nitric oxide induced soluble guanylate cyclase dysfunction or activation: Implications as a disease indicator or in therapyCLEVELAND CLINIC LERNER COM-CWRU2020–2025
Other Languages
- Bengali, Hindi, Kannada, German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
